Targeting DCAF as a novel treatment strategy for therapy-resistant myeloma
Meet the research team developing a myeloma treatment with maximum efficacy and minimal side effects
- Myeloma
Meet the research team developing a myeloma treatment with maximum efficacy and minimal side effects
Northern Territory local Robert Smith had been living on dialysis for 12 years when he was diagnosed with myeloma. Robert discusses the importance that the support of his wife, Jo was in his journey. He takes us through his story — from diagnosis, to what it was like to travel to Adelaide for life-saving treatment and his recovery.
Andrew was the first person in Western Australia to have the life-changing therapy.
Ann Bruce shares the story of her diagnosis, in her own words.
Ciltacabtagene autoleucel (cilta-cel), is being appraised by the Medical Services Advisory Committee (MSAC) for listing on the Medicare Benefits Schedule.
Dr Piers Blombery explains the basics of molecular testing which informs the treatment of blood cancer.
Associate Professor Michael Dickinson says CAR T-cell therapy is a 'revolutionary step forward'.
To mark Myeloma Awareness Month, Faye Johnsen shares her inspiring approach to living with the incurable blood cancer.
Janice says she "wouldn't be here" had she been diagnosed two years earlier.